Toxicity of sunitinib plus bevacizumab in renal cell carcinoma
- PMID: 20439632
- DOI: 10.1200/JCO.2009.27.1759
Toxicity of sunitinib plus bevacizumab in renal cell carcinoma
Comment on
-
Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.J Clin Oncol. 2009 Mar 20;27(9):1432-9. doi: 10.1200/JCO.2008.19.0108. Epub 2009 Feb 17. J Clin Oncol. 2009. PMID: 19224847 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
